One app download and you’re sending Bitcoin lightning-fast with zero channel drama. Grubles left Blockstream to build Bark at ...
Idorsia thanks Alberto Gimona - most recently Head of Global Clinical Development and Medical Affairs - and wishes him all the best for a well-deserved retirementAmer Joseph joins Idorsia as EVP, Chie ...
Press Release - The Africa Centres for Disease Control and Prevention (Africa CDC) is pleased to announce the appointment of a new group of senior leaders to reinforce the institution's capacity to ...
GSK’s Exdensur receives China NMPA approval for the treatment of chronic rhinosinusitis with nasal polyps: London, UK Thursday, April 9, 2026, 09:00 Hrs [IST] GSK plc announced ...
Companies ride the next wave of reshoring and nearshoring, with supply chain and labor issues at the forefront.
Microsoft is losing another veteran executive. Julia Liuson, head of Microsoft’s developer division (DevDiv), is resigning ...
Japan’s Shionogi is joining the spate of drugmakers to announce manufacturing commitments in the U.S. since last year, albeit ...
From a more modest cleaning simulator to a DOS-inspired monster brawl, a round up of brand new gems from the indie world Also ...
It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...
In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...
TAMPA, Fla., April 7, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to ...
As drugmakers strive to fine tune the delivery of their medications for better convenience and patient adherence, Halozyme is putting a recent acquisition in the space to work, thanks to a new tie- | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results